Source: Annual Congress 2006 - Systemic effects of obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
N. Koyama, T. Suzuki, M. Yamauchi, K. Makinodan, S. Tamaki, A. Fukuoka, K. Tomoda, M. Yoshikawa, H. Ishizashi, H. Yagi, M. Matsumoto, Y. Fujimura, H. Kimura (Kashihara, Japan). Unusually large von Willebrand factor multimers might be involved in cardiovascular events in patients with obstructive sleep apnea syndrome. Eur Respir J 2006; 28: Suppl. 50, 2438

Member's Comments

No comment yet.

Related content which might interest you: Reduced larger von Willebrand factor multimers at dawn in OSA plasmas reflect severity of apnoeic episodes}, Source: Eur Respir J 2012; 40: 657-664 Year: 2012 Reduced larger von Willebrand factor multimers at dawn in OSA plasmas reflect the severity of apnoeic episodes Source: Annual Congress 2013 –Sleep disordered breathing in special situations I Year: 2013 Adiponectin is not a cardiovascular risk factor in otherwise healthy subjects with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009 Is obstructive sleep apnea syndrome a risk factor for pulmonary thromboemboli? Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects II Year: 2011 Plasma vascular endothelial growth factor levels in patients with obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 564s Year: 2004 Changes of plasma von Willebrand factor in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 138s Year: 2007 Is obstructive sleep apnoea a risk factor for cardiovascular disease? Source: Annual Congress 2005 - Cardiovascular disease and obstructive sleep apnoea: risks and remedy Year: 2005 Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea Source: Eur Respir J 2009; 33: 574-580 Year: 2009 Vascular endothelial growth factor in sleep apnea syndrome and chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 362s Year: 2005 Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 Obstructive sleep apnea syndrome as factor of arrhythmic syndrome emergence and increase of cardiovascular risk in patients with COPD Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing Year: 2013 Investigation of various factors in obstructive sleep apnea syndrome patients Source: Eur Respir J 2006; 28: Suppl. 50, 194s Year: 2006 Conicity index as prognostic factor of major cardiovascular events in obstructive sleep apnea Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification Year: 2020 Platelet function in patients with obstructive sleep apnea syndrome characterized by means of membrane bound P-selectin expression Source: Eur Respir J 2002; 20: Suppl. 38, 214s Year: 2002 Obstructive pulmonary disorder is a potential risk factor of cardiovascular diseases in obstructive sleep apnea Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008 Mean platelet volume in obstructive sleep apnea patients. Another link to cardiovascular disease? Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain Year: 2011 Autoantibody against NBL1 in obstructive sleep apnea patients with cardiovascular disease Source: International Congress 2017 – New insights into the understanding of sleep and the consequences of sleep apnoea Year: 2017 Impaired glucose tolerance and other cardiovascular risk factors in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009 Mean platelet volume in patients with obstructive sleep apnea syndrome and its relationship with cardiovasculer diseases Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities Year: 2011 Sleep apnoea syndrome, a causative factor of nocturnal microalbuminuria Source: Eur Respir J 2003; 22: Suppl. 45, 90s Year: 2003